Pain Patch Market Highlights
According to MRFR analysis, Pain Patch Market Is Projected to Grow at a CAGR of 4.8% during the forecast period of 2019 to 2025 and is likely to be valued at USD 29.5 Billion by 2025.
Pain patches are used to manage pain caused due to neurological diseases, injury, cancer pain, and others. The pain patches are transdermal drug delivery devices that release the active substance or opioid into the skin to reduce the pain.
The growth of the Global Pain Patch Market is determined by numerous factors such as an increasing number of patients having joint pain, muscular pain, a growing geriatric population with either one of the disease-causing pains increases the demand for pain patches. Also, the increasing demand for the alternative of oral drug for pain management rises the market growth. However, the side effects associated with the pain patches and lack of awareness about the product are likely to hamper the growth of the global pain patch market during the forecast period.
Pain Patch Market Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas has been segmented into North America and Latin America, with the North American market being divided into the US and Canada. The Americas is projected to hold the largest market share owing to the increasing number of patient suffering from central nervous system problem, increasing sedentary lifestyle, and growing demand for innovative technology and product as an alternative to medication for pain management drives the market growth during the forecasted period.
The European pain patch market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The pain patch market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rising geriatric population having a problem in swallowing and the patient sensitive to oral drugs boosts the demand for pain patches in this region. The pain patch market in the Middle East & Africa has been divided into the Middle East and Africa.
Pain Patch Market Segmentation
Pain Patch Market Size has been segmented based on type, mode of administration, therapeutic use, and end-users.
The market, based on type, has been divided into opioid and non-opioid. Opioid is further sub-segmented into immediate-release and extended-release. On the bases of type opioid is likely to hold the maximum market share in the global pain patch market.
The global pain patch market on the basis of mode of administration has been segregated into microneedle patches and active delivery systems with patches.
On the basis of therapeutic use, the market is segmented into neurological disorder, cancer, smoking cessation, and others.
The end-user segment of the market consists of hospitals and clinics, home care, and others. The home care segment is expected to hold the largest share of the market as there is a repetitive purchase of medicines from these locations.
Browse Full Report Details at: https://www.marketresearchfuture.com/reports/pain-patch-market-8569
Pain Patch Market Key Players
Some of the Key Players in the Global Pain Patch Market are LTS Lohmann Therapie-Systeme AG (Germany), NanoVibronix. (US), Mylan N.V.(US), Pfizer, Inc. (US), Teva Pharmaceutical Company (Allergan Plc (Actavis)) (Israel), Endo Pharmaceuticals Inc (Israel), Hisamitsu America, Inc. (America), Johnson & Johnson (US), Teikoku Seiyaku Co., Ltd. (Japan), Sanofi (France), NICHIBAN Co (Japan), The Mentholatum Company (US), and others.
related report
Global Cardiac Mapping Market Research Report —Forecast till 2027
Global Neurodiagnostics Market —Forecast till 2027
Global Lymphedema Diagnostics Market Research Report—Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services
Transdermal Drug Delivery System Market is anticipated to reach USD 81.4 billion by 2024 owing to shift toward sedentary lifestyle that encourages chronic disorders.
TDDS delivers drug through the skin in pre-decided and regulated rate.
Infusion of drug could be effectively monitored and projected creditably through transdermal drug delivery method, which makes it convenient to maintain steady level of drug.
However, transdermal drug delivery system industry is restrained by constrained areas of delivery and slow infusion rate hydrophilic drugs.
Recent years has introduced multiple drugs that could be delivered through transdermal route.
Also, the existing market players in this market are focusing on mergers and acquisition to create niche market.Transdermal drug delivery system market is categorized on the basis of delivery system type, application, and geography.
The global Smoking Cessation Drugs Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the smoking cessation drugs market include GSK, Pfizer, Kimree Technology, Johnson and Johnson, Novartis, Dr. Reddy's Laboratories, The Harvard Drug Group, Perrigo Company, Fontem Ventures, Smoke Away.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Smoking Cessation Drugs Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/smoking-cessation-drugs-market/download-sampleMarket DynamicsThe increased awareness about the benefits of quitting smoking, like reduced risk of heart disease and lung cancer, will be the primary stimulant boosting the demand for cessation drugs.
Several initiatives by non-government and government organizations to educate and help people quit smoking will benefit the market's growth.
The increasing popularity of alternatives like e-cigarettes, transdermal patches and their effectiveness in reducing the nicotine craving in smokers will be the major market players.
Smoking Cessation Product Sales Grow by 12% in 2018, E-Cigarettes Lead the Rally: Fact.MR StudyGrowth prospects of the smoking cessation products market are moderately attributed to smoke-free air laws, as these laws limit promotion and advertising of tobacco products and indirectly encourage consumers to quit smoking.According to the latest study published by Fact.MR, the smoking cessation products market is expected to witness impressive a 12% y-o-y volume growth in 2018 0ver 2017.
Ongoing anti-tobacco movements and increasing sales of electronic cigarettes (e-cigarettes) as a smoking cessation product are key drivers for the smoking cessation products market, according to Fact.MR.The smoking cessation products market study investigates the key influential factors have procured a rise in the willingness of smokers to quit smoking, which includeThe tobacco epidemic is responsible for over 7 million deaths per year worldwide.Tobacco smoking is the primary cause of a life-threatening disease – Chronic Obstructive Pulmonary Disease (COPD) and it is likely to become the third leading cause of death by 2030.Growing health & wellness trend is encouraging consumers to adopt healthy lifestyle.Stringent laws against tobacco smoking in public places are aiding movements against tobacco smoking.A significant rise in tobacco taxes in most countries is exhorting consumers to quit smoking.A majority of consumers are turning to smoking cessation products to mitigate the withdrawal symptoms and increase the chance of quitting smoking, which is ultimately boosting growth of the smoking cessation products market.E-cigarettes – the Most Commonly Used Smoking Cessation Product is Witnessing Burgeoning Demandconsumers are Despite the ongoing controversies about benefits and hazards of e-cigarettes, most preferring to adopt e-cigarettes as a smoking cessation product.
The recent rise in sales of e-cigarettes is mainly attributed to the rise in its demand among young-adult smokers.Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S_id=2372The Centers for Disease Control and Prevention (CDC) released the ‘2016 National Youth Tobacco Survey (NYTS)’, which finds that e-cigarettes are the most popular smoking cessation product among high school students in the U.S.
The 2018 NYTS revealed that use of e-cigarettes among high school students increased by whopping 78% during 2011-2018.
The adolescent population is resorting to e-cigarettes as a smoking cessation product over its other types, and its reasons may be traced back to the USB flash drive-like shape and the availability of interesting flavors of e-cigarettes.The persistent popularity of e-cigarettes is making a significant impact on imperative business strategies of smoking cessation products market players.
Manufacturers in the smoking cessation products market, such as British American Tobacco plc and Imperial Brands PLC, are planning to boost investments in their e-cigarette facilities to envisage incremental growth in smoking cessation products market in coming years.However, the US Food and Drug Administration (FDA) recently imposed a ban on the flavors used in e-cigarettes.
The titled “Global Antipsychotic Drugs Market” report disclosed by Orbis Research gives the Strategic Overview of the Antipsychotic Drugs industry growth and provides a path to take a proper decision for better business opportunities.The global Antipsychotic Drugs Market was estimated at approximately REDACTED in 2017.
The global market is segmented based on the drug’s mechanism of action, disease indication and region.Get Sample Pages @ http://www.orbisresearch.com/contacts/request-sample/2326203 Among the mechanism of action segments, D2 partial agonists are expected to grow at the industry’s highest rate, owing to innovative drug formulations, the protection of multiple patents on the drugs and the strong product pipelines of key players.
The market for D2 antagonists is anticipated to show declining growth rates due to the severe side effects associated with the drugs and the high rate of discontinuation and withdrawal of these drugs from the market.Antipsychotic Drugs Market Scope of ReportThis report provides a detailed description of the market for antipsychotic drugs.
The report highlights the current and future market potential of antipsychotic drugs and provides a detailed analysis of the competitive environment, regulatory scenario, technological advancements, patent analysis, pipeline analysis, drivers, restraints, opportunities and trends in the market.
Based on disease indication, the market is segmented into schizophrenia, bipolar disorder, major depressive disorder (MDD), and other diseases including anxiety, autism and dementia.
By geography, the market has been segmented into the North America, Europe, Asia-Pacific, South America, and Middle East and Africa regions.
